They realized that drugs targeting BRD2/BRD4 had the best chance to disrupt the virus's MO, and there appears to be at least twice as much literature on JQ1 as there is on RVX-208. Hey, who knows, they probably thought pan-BET is better/safer than selective or had no idea that selective BET was even a thing. IDK.